[DOI] [PMC free article] [PubMed] [Google Scholar] 203.Xu Y., Shen J., Ran Z
Image Credit: azimmytws / Shutterstock.com A recent BMJ study determines whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists by type 2 diabetes (T2D) patients increases the risk of self-harm, suicidal ideation, and suicide as compared to patients prescribed dipeptidyl peptidase-4 (DPP-4) or sodium-glucose cotransporter-2 (SGLT-2) inhibitors
Genetic predispositions in GLP-1 signaling pathways may inform provider conversations about personalization, but genes do not predict exact outcomes
This helps maintain stable blood sugar levels, encourages the body to use stored fat for energy, and reduces cravings for quick sugary fixes without causing a crash
Intense exercise during the first week is unnecessary and may amplify fatigue
5.Is it safe to use during pregnancy or breastfeeding